Precision management of coronary in-stent restenosis

Trends Cardiovasc Med. 2026 Jan;36(1):44-55. doi: 10.1016/j.tcm.2025.07.009. Epub 2025 Jul 23.

Abstract

The advent of percutaneous coronary intervention (PCI) and intracoronary stent development marked a pivotal milestone in the management of acute coronary syndromes, significantly reducing morbidity and mortality worldwide. However, despite ongoing advancements in stent technology, treatment modalities, and diagnostic tools, in-stent restenosis (ISR) remains a prevalent and challenging clinical issue, contributing substantially to the burden of cardiovascular disease. This review provides a comprehensive background of ISR, including its associated risk factors, pathophysiology, and current management strategies. By addressing gaps in ISR management, this review critically evaluates existing approaches and explores potential directions for advancing the field of interventional cardiology. Additionally, supporting data for these strategies are examined, and a diagnostic and treatment algorithm is proposed to guide complex clinical decision-making.

Keywords: Coronary artery disease; In stent restenosis; Percutaneous coronary intervention.

Publication types

  • Review

MeSH terms

  • Clinical Decision-Making
  • Coronary Artery Disease* / diagnostic imaging
  • Coronary Artery Disease* / therapy
  • Coronary Restenosis* / diagnosis
  • Coronary Restenosis* / diagnostic imaging
  • Coronary Restenosis* / etiology
  • Coronary Restenosis* / mortality
  • Coronary Restenosis* / physiopathology
  • Coronary Restenosis* / therapy
  • Humans
  • Percutaneous Coronary Intervention* / adverse effects
  • Percutaneous Coronary Intervention* / instrumentation
  • Percutaneous Coronary Intervention* / mortality
  • Precision Medicine*
  • Predictive Value of Tests
  • Risk Assessment
  • Risk Factors
  • Stents*
  • Treatment Outcome